201 related articles for article (PubMed ID: 31486485)
1. LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
Dai L; Chai CM; Shen TY; Tian Y; Shang ZQ; Niu YJ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6858-6867. PubMed ID: 31486485
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
[TBL] [Abstract][Full Text] [Related]
3. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
5. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
6. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
[TBL] [Abstract][Full Text] [Related]
7. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
Feng F; Chen AP; Wang XL; Wu GL
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
9. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
12. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
Chen JB; Zhu YW; Guo X; Yu C; Liu PH; Li C; Hu J; Li HH; Liu LF; Chen MF; Chen HQ; Xiong-Bing Z
J Cell Physiol; 2019 Aug; 234(8):13592-13601. PubMed ID: 30609030
[TBL] [Abstract][Full Text] [Related]
13. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
Shi XY; Lin JJ; Ge XJ; Shi Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
Ye J; Jiao Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
Chen SG; Wang CH; He RQ; Xu RY; Ji CB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
He SZ; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
